The Veterinary Record
HOME CURRENT ISSUE TABLE OF CONTENTS ARCHIVE SEARCH SUBSCRIPTIONS JOBS FEEDBACK HELP
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Monteiro, A. M.
Right arrow Articles by McKellar, Q. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Monteiro, A. M.
Right arrow Articles by McKellar, Q. A.

The Veterinary Record, Vol 142, Issue 15, 396-398
Copyright © 1998 by British Veterinary Association

Pharmaceutical quality of anthelmintics sold in Kenya

A. M. Monteiro BSc, MSc, PhD1, S. W. Wanyangu BVM, MSc, PhD2, D. P. Kariuki BVSc, MSc2, R. Bain BSc, PhD1, F. Jackson BSc, PhD3, and Q. A. McKellar BVMS, PhD, MRCVS3

1 Department of Veterinary Pharmacology, University of Glasgow Veterinary School, Bearsden Road, Glasgow G61 1QH
2 National Veterinary Research Centre, Kenyan Agriculture Research Institute, Mguga, Box 32 Kikuyu, Kenya
3 Moredun Research Institute, 408 Gilmerton Road, Edinburgh EH17 7JH

Nine anthelmintic products purchased in pharmacies and from agricultural merchants in Kenya were tested for pharmaceutical quality. The concentration of active drug was compared with the claim on the label, and the variability of several products was tested between batches and between bottles within the same batch. All the products purchased claimed to contain levamisole but its mean (sd) concentration varied from 0 to 118·0 (13·3) per cent of that claimed. The concentration of levamisole in different batches of the same product ranged from 0 to 85 4 per cent of that claimed. One product consisting in part of mebendazole was found to contain 73·2 (9·4) per cent of the claimed concentration of this active component and two products consisting in part of oxyclozanide were found to contain 106·0 (14·4) and 120·6 (6·1) per cent of the expected concentration of oxyclozanide.




This article has been cited by other articles:


Home page
 Clin. Microbiol. Rev.Home page
S. Geerts and B. Gryseels
Drug Resistance in Human Helminths: Current Situation and Lessons from Livestock
Clin. Microbiol. Rev., April 1, 2000; 13(2): 207 - 222.
[Abstract] [Full Text] [PDF]


HOME CURRENT ISSUE TABLE OF CONTENTS ARCHIVE SEARCH SUBSCRIPTIONS JOBS FEEDBACK HELP
Copyright © 1998 British Veterinary Association